These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2967756)

  • 1. Neurochemistry of dementia.
    Whitehouse PJ; Unnerstall JR
    Eur Neurol; 1988; 28 Suppl 1():36-41. PubMed ID: 2967756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral metabolic relationships for selected brain regions in Alzheimer's, Huntington's, and Parkinson's diseases.
    Metter EJ; Riege WH; Kameyama M; Kuhl DE; Phelps ME
    J Cereb Blood Flow Metab; 1984 Dec; 4(4):500-6. PubMed ID: 6238975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptides in neurological disease.
    Beal MF; Martin JB
    Ann Neurol; 1986 Nov; 20(5):547-65. PubMed ID: 2947536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is "subcortical dementia" a recognizable clinical entity?
    Mayeux R; Stern Y; Rosen J; Benson F
    Ann Neurol; 1983 Sep; 14(3):278-83. PubMed ID: 6227275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurochemical anatomy of movement disorders.
    Young AB; Penney JB
    Neurol Clin; 1984 Aug; 2(3):417-33. PubMed ID: 6152481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurochemistry of dementia: establishing the links.
    Whitehouse PJ; Gambetti P; Harik SI; Kalaria RN; Perry G; Younkin SI; Tabaton M; Unnerstall JR
    Prog Clin Biol Res; 1989; 317():131-42. PubMed ID: 2574868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dementia and Parkinson's disease: biochemical and anatomo-clinical correlation].
    Dubois B; Hauw JJ; Ruberg M; Serdaru M; Javoy-Agid F; Agid Y
    Rev Neurol (Paris); 1985; 141(3):184-93. PubMed ID: 4001706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortical muscarinic receptors in demented patients with Alzheimer's disease or Parkinson's disease.
    Lange KW; Wells FR; Rossor MN; Jenner P; Marsden CD
    Br J Pharmacol; 1989 Dec; 98 Suppl():817P. PubMed ID: 2611524
    [No Abstract]   [Full Text] [Related]  

  • 9. Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method.
    Kuhl DE; Metter EJ; Riege WH
    Ann Neurol; 1984 May; 15(5):419-24. PubMed ID: 6610384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The concept of subcortical and cortical dementia: another look.
    Whitehouse PJ
    Ann Neurol; 1986 Jan; 19(1):1-6. PubMed ID: 2868689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.
    Sian J; Dexter DT; Lees AJ; Daniel S; Agid Y; Javoy-Agid F; Jenner P; Marsden CD
    Ann Neurol; 1994 Sep; 36(3):348-55. PubMed ID: 8080242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotransmitters and neurodegenerative disorders.
    Kanazawa I
    Clin Ther; 1984; 7 Spec No():48-58. PubMed ID: 6152198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of excitotoxins in heredito-degenerative neurologic diseases.
    Young AB
    Res Publ Assoc Res Nerv Ment Dis; 1993; 71():175-89. PubMed ID: 8093331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
    Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
    Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A review on neurotransmitter in clinical neurology (author's transl)].
    Kanazawa I
    No To Shinkei; 1977 Dec; 29(12):1245-60. PubMed ID: 74257
    [No Abstract]   [Full Text] [Related]  

  • 16. Animal models of Alzheimer's Parkinson's and Huntington's disease. A minireview.
    Antal A; Bodis-Wollner I
    Neurobiology (Bp); 1993; 1(2):101-22. PubMed ID: 8111350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analyzing the subcortical dementia syndrome of Parkinson's disease using the RBANS.
    Beatty WW; Ryder KA; Gontkovsky ST; Scott JG; McSwan KL; Bharucha KJ
    Arch Clin Neuropsychol; 2003 Jul; 18(5):509-20. PubMed ID: 14591446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease-related protein changes in purified neurons from Alzheimer's and Huntington's diseases.
    Selkoe DJ
    Trans Am Neurol Assoc; 1979; 104():70-4. PubMed ID: 162259
    [No Abstract]   [Full Text] [Related]  

  • 20. Deposition of amyloid (A4) protein within the brains of persons with dementing disorders other than Alzheimer's disease and Down's syndrome.
    Mann DM; Jones D
    Neurosci Lett; 1990 Feb; 109(1-2):68-75. PubMed ID: 2138261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.